-
BioMarin Pharmaceutical gets grant for treatment of adolescent PKU patients using AVPAL variant
22 Apr 2024 14:33 GMT
… GlobalData’s company profile on BioMarin Pharmaceutical, Human telomerase RT … key innovation area identified from patents. BioMarin Pharmaceutical's grant … Patent and Trademark Office (USPTO). Credit: BioMarin Pharmaceutical Inc
A recently granted patent …
-
BioMarin Pharmaceutical: Still Has A Lot Of Room For Growth
29 Feb 2024 09:29 GMT
… article highlighted the undervaluation of BioMarin Pharmaceutical (NASDAQ:BMRN), and the … to decline due to the patent expiration, its sales amounted to … be sufficient for regulatory approval. BioMarin is planning to present the …
-
BioMarin appeases an activist
21 Dec 2023 15:49 GMT
… oncology’s hottest space.
BioMarin appeases an activist
Alexander … the new CEO of BioMarin Pharmaceutical, had an unenviable … that attract activist pressure, BioMarin actually makes money, and … GlaxoSmithKline pulls back inhaler patents after FTC warning letter …
-
STAT+: Pharmalittle: FTC challenges ‘inaccurately or improperly’ listed patents; Elliott builds stake in BioMarin
08 Nov 2023 15:44 GMT
… is challenging more than 100 patents on brand-name medicines … that listings for dozens of patents on such medicines as … to withdraw or amend their patent listings, or certify under … hemophilia. Analysts noted that BioMarin’s hard-to-manufacture therapies …
-
BioMarin’s new CEO inherits a profitable company, a pioneering gene therapy, and a brewing activist challenge
08 Nov 2023 15:44 GMT
… take over as CEO of BioMarin Pharmaceuticals next month, inherits … point of relative weakness for BioMarin. The company recently scaled … that attract activist pressure, BioMarin actually makes money, and … over inaccurate or improper patent listings, STAT
-
Global Regenerative Medicine Thematic Research Report 2022 Featuring Novartis, BioMarin, Bluebird Bio, Gilead, Orchard Theraputics, Celyad, Arthrex, Stryker, W.L. Gore, Vericel, & Bayer - ResearchAndMarkets.com
15 Sep 2022 15:44 GMT
… growth forecasts
Mergers and acquisitions
Patent trends
Social media trends
Timeline … companies
Glossary
Companies Mentioned
Novartis
BioMarin
Bluebird bio
Gilead
Orchard Therapeutics …
-
Bristol-Myers, Gilead rise, SVB Financial, BioMarin fall
12 Sep 2022 20:56 GMT
… developer announced agreements to settle patent disputes over HIV treatments.
Yum … update to its financial forecast.
BioMarin Pharmaceutical Inc., down $2.69 …
-
BioMarin: Keep Waiting For The Growth
04 Mar 2022 01:57 GMT
… , I highlighted the undervaluation of BioMarin's (NASDAQ:BMRN) shares … growth. Despite the end of patent protection, Kuvan still brings tens …
-
BioMarin: An Undervalued Leader With Multiple Catalysts In 2021
16 Nov 2020 15:37 GMT
… Besides drug research and discovery, BioMarin operates Manufacturing of active pharmaceutical … : Source: Company disclosures Manufacturing BioMarin manufactures the active pharmaceutical ingredients … a drug falls out of patent protection (typically lasts 7 …
-
The Daily Biotech Pulse: CureVac Close To Coronavirus Vaccine Deal With EU, Entera Bio's Positive Readout, Patent Protection For Co-Diagnostics
20 Aug 2020 12:47 GMT
… -Diagnostics Technology Gets Additional Patent Protection
Co-Diagnostics Inc … Office has granted increased patent protection for the … tests. This new patent further validates the uniqueness … Biotech: Spotlight On Gilead, BioMarin FDA Decisions, IPOs
Entera …